Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585675 · ClinicalTrials.gov registry record
Specimen Banking From Patients With Lung Cancer
A clinical trial of Lung Neoplasms, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01585675 is a study of Lung Neoplasms that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 2,000 participants, above the 376-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (432% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01585675, a study of Lung Neoplasms, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Cancer Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2005-11-03 |
| Est. Completion | 2035-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01585675
The ClinicalTrials.gov registry entry for NCT01585675 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 376-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (432% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT01585675 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01585675 about?
NCT01585675 is a clinical study titled "Specimen Banking From Patients With Lung Cancer". The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
What is the current status of trial NCT01585675?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2005-11-03. Estimated completion is 2035-07-01.
What conditions does trial NCT01585675 study?
This clinical trial studies the following conditions: Lung Neoplasms.
Who is sponsoring clinical trial NCT01585675?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01585675 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
TELESCOPE- TELEhealth Shared Decision-making COaching
RECRUITING · NA
-
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
RECRUITING · NA
-
Circulating Tumor Cells (CTC) in Lung Cancer
RECRUITING
-
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.